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Abstract

In this investigation, a method was developed for the determination of purity of the drug
PNU-10483 using the technique of capillary zone electrophoresis (CZE). CZE was seen as a
potential alternative to the formerly used procedure of ion-pair reversed phase highperformance liquid chromatography (HPLC). Nearly five years earlier, a similar study was
performed, in which an attempt was made to develop a method that used CZE to determine
the purity of bulk drug and the potency of drug tablets. While this development was mostly
successful, sporadically unpredictable results reduced the method's overall viability. These
outliers were thought to be caused by inconsistent performance of the vacuum system on the
first-generation capillary electrophoresis (CE) instrument used, a PE 270A CE system. As a
second-generation instrument had been obtained since that investigation, the procedure that
was developed on the original was investigated again and improved.
Separation was carried out by using an untreated fused silica capillary (72 centimeters (cm)
total, 50 cm to detector, 50 micrometers inner diameter). Sample injection was via vacuum
suction at 5" Hg for 2.5 seconds. The run buffer used was 50 milrimolar (mM) sodium
phosphate, monobasic, adjusted to pH 3.30 using 85% phosphoric acid. The sample buffer
used was 2.5 mM sodium phosphate, monobasic. For an internal standard, pyridine was
chosen, and both it and the PNU-10483 sample were added at a concentration of 0.3
milligrams/millihter. Stabilization of migration times was induced by a rinse cycle of 0.5 molar
sodium phosphate, monobasic adjusted to pH 2.5 with 85% phosphoric acid. The voltage
applied was 25 kilovolts, and the current observed at this level was about 30 microamps.
Detection was on-line at a wavelength of 200 nanometers. Adjusted-area quantitation was
used.

The method was selective, as it could separate all the known process and degradation
impurities of PNU-10483, as well as its internal standard. When using normal assay
concentrations, the procedure was linear over the range 50-120%. For this method, mean
recovery was 100.1%, the relative standard deviation (RSD) was 0.97%, and the correlation
coefficient for the first-order regression of amount found versus amount added was 0.9982.
Furthermore, neither the intercept nor the slope were statistically different from zero or one,
respectively, at the 95% confidence level. Residuals were random, not accumulating at any
one place. For replicate injections of a single sample solution, the RSD was 0.75%. For
single injections of replicate sample solutions at the 100% level, mean recovery was 99.1%
and the RSD was 0.82%. At the 80% level, mean recovery was 99.6% and the RSD was
0.87%. Finally, the developed procedure was applied to several research lots of PNU-10483.
In this study, the developed method was not compared directly to HPLC, but results found in

the earlier study found good agreement between the two techniques, suggesting that CZE
could serve as a valid alternative to HPLC in the purity determination of PNU-10483.

Introduction

Capillary electrophoresis (CE) is a relatively new technique for the separation of molecules,
having been introduced in principle in 1979 and first demonstrated in 1981 (1). CE has
several different potential applications, including the identification of different chemicals and
their structures, indication of substance purity, or assays of substance potency. As is obvious
from its name, CE utilizes the phenomenon of electrophoresis, in which molecules with
different masses and electric charges move at different rates when placed in an electric field.

This process takes place within a narrow fused-silica capillary of from 30 to 100 centimeters
(cm) in length. Substances migrate along a narrow bore within the capillary, which is typically
from 50 to 75 micrometers (|im) in diameter. The entire capillary is usually about 375 |im in
diameter. While the capillary itself is extremely delicate, it is almost totally covered with
polyimide, so as to prevent breakage. In CE, a capillary is filled with an electrolyte solution,
or, run buffer. The ions of this solution allow current to flow through the capillary. Also, as
the run buffer comes into contact with the walls of the capillary, silanol groups from the

fused-silica dissociate, releasing hydrogen ions into the solution. The silanol groups remain
attached to the inside surface of the capillary, giving the walls a negative charge (2).

After a capillary has been rinsed and filled with run buffer solution, a small amount (typically
around 10 nanoliters) of sample in a less concentrated electrolyte solution is injected into the

positive end of the capillary by vacuum suction, electrokinetic force, or gravity injection,

which is a siphoning effect. Once this has been achieved, high voltage (up to 30 kilovolts

(kV)) is applied, causing an electric field to form within the capillary. This field acts upon a
positively charged area near the inner walls of the capillary, setting up a flow toward the

negative electrode. All of the run buffer solution within the capillary flows at the same speed,
setting up what is known as the electroosmotic flow. The electroosmotic flow, in turn,

induces a plug flow, which leads to a high separation efficiency. The sample substances being
examined, however, travel at different speeds, bringing about separation. Generally, samples
migrate in direct proportion to their charge/size ratio. Positively charged ions move faster

than do negatively charged ions, which, in fact, migrate against the field. Migration velocity
can be altered through the manipulation of the polarity of the electric field, temperature,
applied voltage, or different electrolyte compositions (2).

A useful feature of capillaryelectrophoresis is its on-linedetection capability. As samples
migrate along a capillary once voltage is applied, at a certain point they pass throughthe

capillary's detector window, which is a small portion of the capillary where the polyimide
coating has been removed. A light source set at a certain wavelength (k), either in ultraviolet

(UV) or visible regions, shines through this window and into a photoreceptor. If the sample
has specific chromophores, this would be enough to be registered by the photodetector.

However, many of the ions being investigated do not have notable chromophores. In this
case, a run buffer that absorbs lightis used. As samples move through the detector window

displacing the run buffer, more light is able to shine through, thus increasing the signal to the
photoreceptor. The signals received by the photoreceptor are used to construct an
electropherogram, a plot that shows the results of a CE run (2).

Capillary electrophoresis improves upon its predecessor, slab-gel electrophoresis, in several
ways. The most notable advantage held by CE over slab-gel electrophoresis is its ability to
rapidly dissipate the heat that was a major limitation of the older method. This is facilitated by
the extremely narrow capillaries used in CE. Additionally, CE is capable of having far shorter
analysis times and much higher efficiency than slab-gel electrophoresis. As such, several
molecular types that were previously mainstays for investigation with slab-gel electrophoresis

investigation have migrated to CE with excellent results. These include biopolymers, proteins,
peptides, and nucleic acids, which can be sequenced easily using CE. In fact, CE has become

a valuable tool for genomic characterization for the Human Genome Project. Finally, slab-gel
electrophoresis is incapable of on-line detection, unlike CE (3).

While previous modes of electrophoresis did not show much promise for the characterization

of small molecules, CE is quite capable in this area. As such, it has seen much use in this way,
particularly by the chemical and pharmaceutical industries. Pharmaceutical applications exist
that use different modes of CE, such as capillary zone electrophoresis (CZE), micellar

electrokinetic capillary chromatography (MECC), and free-zone electrophoresis, but
comparatively few met strict validation requirements until recently. Those methods that have

shed the so-called "soft" status of previous CE applications are found mostly in the area of
major-component determinations in pharmaceutical formulations (4).

In this study, a method for the determination of the animal health candidate drug PNU-10483
was developed. PNU-10483, whose molecular structure is shown below, was initially

investigated as a human health candidate for the treatment of adult-onset (Type II) diabetes,
but due to two adverse events in phase I trials, development ceased in 1993.
H2N-C-NH-CH2CH2-C-OH
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More recently, it has returned as an animal health candidate for the potential treatment of

obesity in dogs (5). In order to aid the earlier development of this candidate, many assays
using HPLC had been developed, but CZE was also considered as a potential alternative. In
CZE, the capillary is filled with a single buffer and separation occurs only according to the
charge to size ratio. As a result, each analyte forms a zone which moves at a different rate

than other zones (2). The first investigation into such a method met with some degree of
success, but was frequently plagued with unpredictable results. Specifically, outliers were
observed in nearly every series of runs. Investigation into the cause of these outliers

suggested that they were the fault of inconsistent performance of the vacuum system within

the instrument that was used, a first-generation ABI (now PE) 270A Capillary Electrophoresis
System (3). Two years after the first study had been completed, a second generation
instrument, the PE 270A-HT Capillary Electrophoresis System had been purchased. This

instrumentfeatured an improved vacuum system, a change which held the possibilityof
making the determination of purity of PNU-10483 by CZE truly viable (5).

Before any method can be used for the testing and/or analysis of substances such as

pharmaceuticals, its performance must be evaluated with respect to several parameters. One
such parameter is specificity, or, whether the method is specific to the component of interest,
without interference from similar substances such as breakdown products or impurities.

Another parameter important to method vahdation is sensitivity, which determines the limit of
detection (LOD) and the limit of quantitation (LOQ) for the method. The LOD can be
described as the lowest amount of the sample that can be distinguished from background
"noise," whereas the LOQ is the smallest sample concentration at which reliable quantitation

can be performed. Usually, these values are judged from the method's signal-to-noise (S/N)
ratio. S/N ratios greater than or equal to 3:1 for the LOD and 10:1 for the LOQ are usually
sufficient (2).

Linearity is also found for method validation. It is assessed by running samples for
concentrations usually ranging from about 50% to 150% of normal. Ideally, the amounts of

sample found through CE should correspond with the amounts added, forming a linear plot.
The intercept of such a first-order regression plot should not be statistically different from
zero, while the slope should not be statistically different from one. The correlation coefficient
is also calculated in this test (2).

Finally, precision is another parameter important to method validation. To test precision,

identical runs are repeated several times, either all from a single sample preparation or each
from a different but identically prepared sample preparation. Results are obtained from the

amounts of sample found and the relative standard deviation (RSD) determined from these
values. In CE, RSD values below 2% are generally acceptable (2).

If CE is ever to be considered as an equal to the technique of high-performance liquid

chromatography (HPLC), more work must be done for it to match the performance of HPLC.
When using HPLC, relative standard deviation values of < 1% are commonplace, lower than
the usual RSDs of less than or equal to 2% for major components obtained through CE.
Furthermore, to obtain even this level of performance from CE methods requires that careful

attention be paid to the regulation of several parameters, including temperature, pH, the state
of the surface of the capillary, and the mode and length of the sample introduction.

Additionally, an internal standard is usually required in order to attain low RSD values. If
these criteria are properly adjusted and/or maintained, performance more in Hne with HPLC is

possible. Also, CE performance will hkely improve as the development of next-generation CE
instruments continues (3).

Methods and Materials

Equipment

Early work in the development of this method was performed on a first-generation PE 270A
Capillary Electrophoresis System, but validation experiments were all performed on the

second-generation PE 270A-HT Capillary Electrophoresis System. The capillaries used were

purchased already prepared by PE. They were 50 micrometers (|im) in diameter, composed

of fused silica, and precut to a length of 72 centimeters (cm) (=Lt). The detector window was
at 50 cm from the start of the capillary (=Ld). Each capillary used was pretreated with 1 N
NaOH for approximately 20 minutes, and rinsed in this manner again as required to restore
proper functioning. The instruments' variable wavelength detectors, which utilize deuterium
sources, were set to 200 nanometers (nm). This wavelength had been previously determined
to be optimal partly as a result of the lack of notable chromophores in the PNU-10483
molecule. Sample injection was hydrostatic by vacuum at 5" Hg and sustained for 2.5

seconds. The capillaries were all maintained at a temperature of 30°C by the air-driven,
thermostat-controlled compartments of both instruments used. Each run consisted of two 3

minute rinses, first with phosphate wash solution and secondly with the run buffer, followed
by the injection of the sample and the application of voltage for from 10 to 12 minutes, as

necessitated. Later in the study, septa were placed on top of both buffer and sample vials in
an attempt to curb the evaporation of these solutions, particularly the sample, which contained
semi-volatile pyridine. In addition, a 1:1 watenethylene glycol refrigerant solution was

circulated through the autosampler tray of the PE 270A-HT at 6°C by a Neslab RTE-5DD
Refrigerated Circulating Bath. This was done to further reduce the effects of volatihzation of

the internal standard. The PE 270A-HT can be controlled one of two ways, either directly
from its built-in microprocessor or by an external personal computer through an interface.

The former method was found to be simpler and was used in this study. Data collection was

carried out by a PE Nelson 900 Series Interface under the control of the program
"AccessChrom," and was performed at the rate of 5 points per second.

Reagents

Phosphate buffers were prepared using sodium phosphate, monobasic, monohydrate, which
was obtained from Mallinckrodt (AR grade). The buffers were adjusted to the required pH

levels with 85% phosphoric acid, also acquired from Mallinckrodt (AR grade). Purified
water, used to prepare buffer solutions, was obtained from a Milli Q system from Millipore.
To minimize the chances of the capillaries becoming plugged, all solutions were filtered
through 0.45 |im, HPLC-certified filters from Gelman Sciences. Each solution was also
vacuum ultrasonicated, in order to remove dissolved gases. The internal standard, pyridine,
was obtained from Burdick & Jackson, and new internal standard solutions were prepared

daily, as the pyridine was subject to volatilization. In general, new solutions of all types were

freshly prepared as often as possible, as the performance of the assay was quite sensitive to
their ages. All known and possible process impurities of PNU-10483 were obtained from
Aldrich, Mallinckrodt, Sigma, and P & U Chemical Research Preparations (now Chemical and
Fermentation Operations). For each of the developmental and vahdation studies, milled PNU10483 bulk drug from lot 24968-MAK-95 was used. PNU-10483 lot 24968-MAK-101 was
used as the reference standard in the assay of research lots of PNU-10483. This lot was most
recently characterized in 1996.

Methodology

Much of the validation work of the previous study laid the ground for this study, so a few
areas did not need to be dealt with directly here. For example, checks on potential sources of
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interference to assay stability were performed in more detail earher, but were briefly confirmed
in this study, nonetheless. A satisfactory internal standard, pyridine, had also already been

indentified in the previous study. Furthermore, the compositions of the solutions used varied
only slightly from those found to be optimal in the earlier study (3). One alteration was the

adjustment of the concentration of PNU-10483 in the sample solution to 0.3 milligrams
(mg)/milliliter (ml) from 0.2 mg/ml. This was carried out by adding pyridine to the sample
buffer at 0.3 mg/ml, measuring out 10 ml of the resultant solution, and adding approximately

3.0 milhgrams (mg) of PNU-10483 in a suitable vial. Also, sodium phosphate was used in the
buffer solutions rather than potassium phosphate. The wash solution used, 0.5 molar (M)
phosphate buffer at pH 2.5, did not need to be altered in any way.

Linearity and recovery results for this method were investigated for concentrations from 50120% that of the original assay concentration. Precision, in turn, was measured for replicate
injections of a single sample preparation and also for single injections of replicate sample
preparations at 100% and 80% concentration levels. Quantitation was performed according

to adjusted area, Aadj, in which Aadj = Aunadj/tm; where tmis the migration time (5).
Furthermore, any one run buffer vial was not used more than two successive times, in order to

prevent an inward drift of migration times. Also, the vials containing the 0.5 M phosphate
wash solution were switched after every second run.

Results
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Method Development

This study started at the optimal conditions established in the earlier study. Specifically,
analyte concentration of 200 parts per million (ppm), 200 nm detection, sample introduction
for 2.5 seconds via vacuum injection at 5" Hg, and application of voltage at 30 kilovolts (kV)

(resulting in a current of approximately 30 microamps (pA)). With these conditions, a
electrophoresis run was executed, generating an electropherogram seen as Figure 1.

Surprisingly, response for the PNU-10483 peak was smaller than had been expected, showing
a S/N ratio. As an initial effort to improve response, electrokinetic injection was used in the
place of vacuum injection, applying 5 kV for 5-20 seconds. However, these conditions
resulted in even smaller resultant peaks, most likely due to the fact that PNU-10483 had
insufficient electrophoretic mobility. In addition, pyridine displayed a broader peak when
injected electrokinetically.

The buffer and sample solution pH of 3.3 was found to be optimal in the earlier study, but

some work was done in this study to confirm these results. Once again, pH 3.3 showed the
most symmetrical peak shape of any of the pH levels tested. At pH < 3.30, the PNU-10483

peak displayed notable tailing, and at pH > 3.30, fronting became a problem with this peak's
shape.

In the previous study, potassium phosphate was used in both the sample and run buffers and
also in the wash solution. However, it has been noted in other CE studies that the closer the
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match between the electrophoretic mobility of the analyte and of the buffer counter ion, the
more symmetric peak shape is. In the interest of taking advantage of this behavior, the effect
on peak shape of sodium, lithium, and potassium salts of dihydrogen phosphate were

compared. Each run buffer was prepared at 50 mM and each sample buffer at 2.5 mM for the
salt of each ion, and the pH of each was adjusted to pH 3.3 with 85% phosphoric acid (the pH

of the sample buffer decreased to 3.2 when 200 ppm PNU-10483 was added). Table 1 shows
the results found by this analysis. Potassium and sodium ions were observed to effect
similarly desirable peak shapes. More careful scrutiny of these peaks at 5% or peak base
values showed sodium to have slightly preferable peak shape, and, as such, NaH2P04 »H20

was used in the run and sample buffers and the wash solution.

As noted previously, signal-to-noise ratios were a bit questionable at the start of this study. In
an attempt to rectify this situation, an investigation into the effects of higher analyte

concentrations was initiated. Until this point, PNU-10483 in the sample solution was added at

a concentration of approximately 200 micrograms (|j.g)/ml, which was found to be optimal in

the previous study. PNU-10483 concentrations in a range of approximately 200-400 [ig/ml
were tested; the results are seen in Table 2. In column 6, an F parameter is calculated which

shows about how quickly peak height increases in comparison to peak area. Peak height was
seen to increase with concentration at a faster rate than did peak area. For each concentration
above 200 ppm, overall performance decreased, but at a relatively slow rate until the

concentration of 300 ppm was reached. As such, analyteconcentration from this point on
were increased to 300 ppm. It was worth noting that even after this adjustment, the S/N
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ratios were still somewhat lacking, a point that would seem to show that this method would
benefit from techniques that enhance the sensitivity of detection, such as "z-cell" capillaries,
whose detector windows are in the shape of the letter "Z," thereby extending the path length
for detection and improving response (2, 5).

Specificity was tested only briefly, as this had already been more extensively covered in the
earher study (3). Nevertheless, it was not completely certain that the changes made to the
buffer solutions would not adversely affect selectivity. Therefore, a mixture of pyridine and
PNU-10483 and the process and/or degradation impurities guanidine, PNU-10483 lactam

(PNU-92576), P-alanine, cyanamide, and dicyandiamide were added to sample buffer and
separated by CZE. The results of this run are seen in Figure 2. It is interesting to note that
while dicyandiamide produced a peak in the earlier study, it did not here. Later, this was
thought to be caused by the decomposition of dicyandiamide to cyanamide, as the
dicyandiamide used was several years old. Also, cyanamide did not elute as it was uncharged
under the assay condition of pH 3.3 and exhibited small electroosmotic flow was small.

Regardless, when these results and those from the previous study were combined, it could be

concluded that both pyridine and PNU-10483 exhibited separation from all other components.
Table 3 gives additional information about each of the impurities tested.

Validation Results

Early series of runs in the validation process gave very high RSD values; these were

subsequently attributed to the volatilityof the pyridineinternal standard. An example of the

13

degradation ofresults that often occurred from one day to the next can beobserved in Figure
3, as well as a blank run which was added for comparison. In order to stop or slow the

evaporation of pyridine, septa were placed over the sample vials and a refrigerated recirculator
was used to maintain the temperature of the PE 270A-HT's autosampler tray at 6°C.

Additionally, sample filtering, which had previously been used until early validation, was
eliminated. It was found that this technique was not absolutely necessary and may or may not

havehad a negative effect on the results. Also, a greater amount of sample solution was
added to each sample vial (approximately 300 [i\ or more), in order to decrease headspace and
further counteract the volatility of the internal standard. After these measures had been

enacted, performance improved notably, but could still show considerable variation from one

day to the next, particularly in peak shape. This inconsistency in performance was later seen
to be directly related to the ages of the buffer solutions used. As a result, solutions were
prepared fresh daily from this point on. After all extra precautions were taken, the
electropherogram seen in Figure 4 was produced. This separation was achieved with the use
of a sample buffer of 2.5 mM, pH 3.30 NaH2P04»H20 containing 0.3 M-l/ml pyridine and 300
ppm PNU-10483, a run buffer of 50 mM NaH2P04•H20, pH 3.30, and a wash solution of 0.5
M NaH2P04»H20, pH 2.50.

Precision

Precision for this method was determined by performing six replicate injections of one sample
preparation and single injections of six replicate sample preparations at 100% and 80% normal

concentration (300 ppm). The results obtained from the replicate injection runs are shown in
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Table 4. The RSD was found to be 0.75%. While each sample vial was sealed by a septum in
these runs, the refrigerated recirculator was not utilized. The results of the replicate

preparation injections at 100% are shown in Table 5. Mean recovery for this set was seen to
be 99.1% and the RSD was 0.82%. This mean recovery value was just over one standard

deviation away from 100%, an acceptable result, but one probably attributable to the variation

in performance seen from day to day until the previously mentioned preventative measures
were taken. The results for the replicate preparations at 80% sample concentration are shown
in Table 6. Mean recovery for these runs was 99.6%, while standard deviation (SD) was
0.87% and RSD was 0.87% as well. The results of these investigations showed that the assay

maintained precision at an acceptable level.

Linearity/Recovery

Table 7 shows linearity and recovery results for the range of 50-120% of normal sample

concentration. The levels of 130% and 140% were also performed but exhibited uneven and

unsatisfactory results. Specifically, recovery at 130% was approximately 85% while recovery

at 140% was approximately 105%. A negative display of nonlinearity was not surprising at

such high values, but as the 130% level value was low and the 140% level value was high, it is
not certain what the cause of these nonlinear values was. Mean recovery for these runs over
the range of 50-120% was 100.1% and the RSD was seen to be 0.97%.

A first-order regression plot made from the recovery results that were obtained is shown in

Figure 5. The intercept found was 0.027 and was not statistically different from zero. The
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slopefound was 0.990 and was not statistically differentfrom one. The lower and upper95%
intercept values were -0.0650 and 0.119 while the lower and upper slope values were 0.955
and 1.025. These were acceptable results, meeting usual vahdation expectations. Figure 5

also includes a plot of the residuals, which appeared to be distributed about the regression line
without any bias.

Application of Developed Assay to Research Lots of PNU-10483

Having been fully developed at this point, the assay was next used to examine six research lots
of PNU-10483, each of which was at least five years in age. The determination was made

duplicate. The lot 24968-MAK-101 was used as the reference standard and upon its most
recent examination in 1996, was assigned a purity value of 99.8%. The results obtained from
these runs are displayed in Table 8. While no comparison to HPLC was made, all values were
within expectations. Furthermore, the assay was well behaved.

Conclusion

While this study was very similar to one performed nearly five years ago, the previous study
was hampered by the appearance of outliers in almost every data set. These anomalies were

later attributed to the imperfect vacuum system of the first-generation CE system used. The

problems experienced in this earlier study made it impossible to meet vahdation expectations
at that time (3). However, second-generation CE systems that have been introduced since

1993 have far fewer of the weaknesses that handicapped their predecessors. In particular,
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vacuum performance has been greatly enhanced. The method introduced in the previous
study, when modified to perform on the newer instrument, shows no statistical outliers and
passes validation requirements. While sensitivity could be improved somewhat, either by the

use of z-cell capillaries or similar methods, it was sufficient enough to be deemed acceptable
on a standard capillary. Therefore, when performed on more advanced CE systems, this
method is now a viable and orthogonal alternative to HPLC for the determination of purity of
PNU-10483.
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Table 1

Effect of Buffer Counter Ion on Separation Efficiency*
Ion(M)

W1/2 (S)

w5% (s)

Wbase (S)

N1/2

K

3.5

7.7

10.7

145107

130557

3.1

8.1

11.2

178516

113077

5.4

10.0

13.8

56220

72453

5.1

9.4

12.1

62251

79475

4.1

7.6

10.7

96257

122622

7.5

10.2

99164

126325

Li

Na

4.1

N5%

* All values pertain to PNU-10483
Run buffer: 50 mM MH2P04, pH 3.30
Sample buffer: 2.5 mM MH2P04, pH 3.3

Table 2

Effect of Sample Prep Concentration on Assay Performance
Sample

Area

200

42050

225

49238

1.171

13046

1.137

250

55738

1.326

13050

1.137

A/A200ppm

HGlV)

H/H200ppm

F*

w1/2

N1/2

0.061

123246

0.971

0.063

113096

0.857

0.072

87674
87219

11478

275

61542

1.464

14534

1.266

0.865

0.072

300

69484

1.652

16316

1.422

0.861

0.072

85390

400

94268

2.242

20110

1.752

0.781

0.080

68089

* F = (H/H200ppm)/(A/A200ppm)
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Table 3

Possible Interferences: Bulk Drug, Process Impurities, Degradation Products, and
Internal Standard
Structure

Compound

Source

(5-Alanine

Starting material

o
11

H2N-CH2CH2C-OH
Possible process
impurity and
degradation product
Possible degradation
product

uanidine

•
Urea

Cyanamide

Starting material

Dicyandiamide
(PNU-96,629)

Process impurity

PNU-10,483 Lactam

Degradation product

.7
H2N-C - NH 2

0
11

H2 N- C - NH2
H,N-C=N

N H

H2N-C -NH - C=N

(PNU-92,576)
PNU-10,483

Bulk drug

N H
I I

H2N-C-NH-CH2CH2C-OH
Pyridine

Selected Internal
Standard

All runs were in 50 mM NaH2P04 • H20 buffer at pH 3.3; 25 kV applied potential; 2.5 s
hydrostatic injection.
Table 4

Precision for Replicate Injections of a Single Sample Preparation
Run

Standard Factor*

1

ft.35378

2

4.28313

3

4.31224

4

4.33969

5

4.27223

6

4.33033
x = 4.31523

fRSD = 0.75%
* Std. Factor = (wt/Aadj)10483(Aadj)IS
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Table 5

Precision Results for Single Injections of Replicate Sample Preps at the 100% Level
Run

% Recovery

1

99.3

2

98.7

3

100.6

4

98.6

5

98.4

6

98.8

x = 99.1%

RSD for standards (n = 6) = 0.86%

s = 0.81%

RSD = 0.82%
Table 6

Precision Results for Single Injections of Replicate Sample Preps at the 80% Level
Run

% Recovery

1

98.8

2

98.8

3

100.5

4

100.2

5

100.5

6

98.9
x = 99.6%

RSD for standards (n = 6) = 0.77%

s = 0.87%

RSD = 0.87%
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Table 7

Linearity/Recovery Results for PNU-10483
Amount Added (mg)*

Amount Found

% Recovery

50

1.447

1.446

99.9

60

1.857

1.849

99.6

70

2.154

2.149

99.8

80

2.356

2.367

100.5

% of Assay Cone.

80

2.306

2.339

101.5

90

2.619

2.624

100.2

100

2.946

2.946

99.4

100

3.022

3.002

100.0

110

3.271

3.325

101.7

120

3.750

3.690

98.4
x = 100.1%

RSD for standards (n = 8) = 0.67%

s = 0.97%
RSD = 0.97%

* in 10 ml

Table 8

Purities Determined for Research Lots of PNU-10483 Using the Developed CZE Assay
Sample

Result (%)

Sigma 86F0339

98.0
98.6

Sigma 76F0608

99.3

99.0
24272-MAK-18

99.6
98.3

25944-MAK-12

98.5

97.7
24958-MAK-95

100.6

(A)0219-MAK-096

97.0

100.5

98.0
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Figure 1. Results of capillary electrophoresis using the optimal conditions established by the
earlier study, representing the state from which current development started. Conditions:
capillary, 50/72 cm, 50 [im id; run buffer, 50 mM KH2P04, pH 3.30; sample buffer, 2.5 mM
KH2P04, pH 3.3; internal standard, 0.3 |il pyridine/ml sample buffer; sample concentration,
200 ppm PNU-10483; injection, vacuum, 2.5 s; temperature, 30°C; voltage (V), 25 kV;
wavelength (k), 200 nm.
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Figure 2. Separation of several impurities from pyridine (internal standard) and PNU-10483.
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Figure 3. Electropherogram showing slightly degraded performance (top) compared with
optimal performance (middle). A blank is shown at the bottom.
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Figure 4. End product of development, full scale. Conditions: capillary, 50/72 cm, 50 |im
inner diameter; run buffer, 50 mM NaH2P04, pH 3.30; sample buffer, 2.5 mM NaH2P04, pH
3.3; internal standard, 0.3 |J,1 pyridine/ml sample buffer; sample concentration, 300 ppm PNU-

10483; injection, vacuum, 2.5 s; temperature, 30°C; V = 25 kV; X= 200 nm.
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Amt Addded vs Amt Found for PNU-10483

4 -i

Amt Added v Amt Found

Amt Added (mg) Regr

3 -

•o

5 2
O

Coefficients:

b[0]« 0.0272437568

E

b[1J- 0.9897606667

<

r2* 0.9981513762
1 -

Amt Added (mg)

X Variable 1 Residual Plot
0.1 -r:

«

0.05

3

♦

TJ

♦
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^

mmm

+2*
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X Variable 1

Figure 5. First-order regression curve for recovery over 50-120% of the nominal assay
concentration. The corresponding residuals plot is also shown.
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